Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/2012
09/05/2012CN102655875A Improved peptidomimetic macrocycles
09/05/2012CN102655874A Heparin cofactor II fragments with anti-inflammatory and anti-coagulant activity
09/05/2012CN102655873A Combinations of a specific HCV NS5A inhibitor and an HCV NS3 protease inhibitor
09/05/2012CN102655872A Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
09/05/2012CN102655871A Infectious clones of Torque teno virus
09/05/2012CN102655868A Combination preparations comprising a cytokine antagonist and corticosteroid
09/05/2012CN102653783A Application of HVEM (herpesvirus entry mediator) gene in preparing product for liver cancer diagnosis and prognosis prediction
09/05/2012CN102653553A Polypeptide having high affinity with beta clamp of mycobacterium tuberculosis
09/05/2012CN102652836A Targeting drug release anticancer protein or polypeptide polymer prodrug and preparation method thereof
09/05/2012CN102652830A Application of Cathelicidin-BF (bungarus fasciatus) in preparation of antineoplastic medicament
09/05/2012CN102652829A Extraction method of ginseng peptide
09/05/2012CN102652828A Polypeptide-k buccal tablet
09/05/2012CN102212527B Porcine alpha-interferon gene with efficient expression and high antiviral activity and application of expression protein thereof
09/05/2012CN102133392B Water splashing compound preparation for boosting exuviation of shrimps and crabs, hardening shells, preventing diseases and resisting stresses
09/05/2012CN102085370B Oral spray for inflammatory diseases of oral cavity and preparation method thereof
09/05/2012CN102060913B Heptapeptide combined with human serum albumin and application thereof
09/05/2012CN101991840B Method for preparing prostate cancer-resisting mussel enzymolytic extract and application thereof
09/05/2012CN101947314B Novel aqua for treating beriberi and preparation process thereof
09/05/2012CN101947313B Novel effervescent tablet for treating beriberi and preparation process thereof
09/05/2012CN101933897B Recombinant human endostatin temperature-sensitive gel composition for injection
09/05/2012CN101926984B Preparation method of artificial nano red blood cells
09/05/2012CN101926983B Artificial nano red blood cells
09/05/2012CN101906140B Aliphatic chain and YIGSR pentapeptide conjugate, and synthesizing method and application thereof
09/05/2012CN101905016B Novel application of trefoil factor 3
09/05/2012CN101899091B Fatty alkyl pentapeptide conjugate, preparation method thereof and application thereof in medical science
09/05/2012CN101899084B (3S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid kyrine conjugate, preparation method and application thereof
09/05/2012CN101892210B Sipunculus nudus plasmin and preparation method thereof
09/05/2012CN101891801B Saturated aliphatic chain alcohol RGD (Arginyl-Glycyl-Aspartic acid) pentapeptide diester compound, synthesis method and application thereof
09/05/2012CN101838318B Anti-HIV-I polypeptide and coding sequence and use thereof
09/05/2012CN101838313B Mimic short peptide 9B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/05/2012CN101838312B Mimic short peptide 12B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/05/2012CN101804194B CTLA4lg and derivatives thereof used for resisting bacteria
09/05/2012CN101775072B Glial cell line-Derived Neurotrophic Factor (GDNF) fusing penetrating peptides
09/05/2012CN101773664B Fish bone scale collagen peptide for preventing and curing egg and poultry fracture
09/05/2012CN101709292B Recombinant adenovirus, and preparation method and application thereof
09/05/2012CN101671397B Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof
09/05/2012CN101648994B Azepine argireline or pharmaceutically acceptable salt thereof and preparation method and application thereof
09/05/2012CN101627049B Synthetic peptide amides
09/05/2012CN101626779B Oral disinfectant, food additive comprising the disinfectant
09/05/2012CN101568538B Thiophene analogues for the treatment or prevention of flavivirus infections
09/05/2012CN101568328B Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
09/05/2012CN101525611B Fusarium plasmin and preparation method thereof
09/05/2012CN101437501B Prolongation of survival of an allograft by inhibiting complement activity
09/05/2012CN101428137B Composition for diminishing neutral fat in blood
09/05/2012CN101396553B Recombined human blood vessel endothelial inhibin sustained-release injection composition
09/05/2012CN101389273B 基因或药物递送系统 Gene or drug delivery systems
09/05/2012CN101360508B Pharmaceutical composition, food or drink, or feed for intestinal disease
09/05/2012CN101360486B Nanoparticles for protein drug delivery
09/05/2012CN101341169B FSH mutants
09/05/2012CN101296704B Methods for reducing CD36 expression
09/05/2012CN101248177B Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same
09/05/2012CN101240032B Broad spectrum influenza virus resistant antagonistic peptide nasal spray preparation and application
09/05/2012CN101168560B N-substituted peptide amide, pharmaceutical composition and use thereof
09/05/2012CN101144082B Recombination human ciliary neurotrophy factor, mutant and application thereof
09/05/2012CN101130060B Medical composition containing dalbavancin
09/05/2012CN101125207B Exendin or its analogs with polyethylene group and its preparation and application
09/05/2012CN101035557B Preparation method of pharmaceutical formulation comprising crystalline insulin and dissolved insulin
09/05/2012CN101014613B Chimpanzee adenovirus vaccine carriers
09/05/2012CN101002945B Novel complex used for treating tumor
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012US8258271 mTOR kinase-associated proteins
09/04/2012US8258264 Process for producing albumin preparation
09/04/2012US8258263 Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
09/04/2012US8258262 N-terminally chemically modified protein compositions and methods
09/04/2012US8258258 Dimeric or multimeric microproteins
09/04/2012US8258256 Compositions and methods for the treatment of cancer
09/04/2012US8258252 Lactic acid-glycolic acid polymer having ratio or weight average molecular weight and number average molecular weight of about 1.90 or lower, or a salt thereof, and a physiologically active substance; for treating prostate cancer, prostatomegaly, endometriosis, hysteromyoma, metrofibroma, breast cancer
09/04/2012US8258153 Methods, compositions, and kits for the treatment of ophthalmic disorders
09/04/2012US8258108 Gene expression inhibition by contacting cells which express kinase suppressor of Ras (KSR) with a nucleic acid which is complementary to a portion of the mRNA encoding KSR; antitumor, anticarcinogenic, antimetastasis and antiproliferative agents
09/04/2012US8258106 Immunostimulatory nucleic acid molecules
09/04/2012US8258102 Gene and polypeptide sequences
09/04/2012US8258101 Peptide-based compounds
09/04/2012US8258100 Ligand/lytic peptide methods of use
09/04/2012US8258098 Antitumoral treatments
09/04/2012US8258097 Amino acid derivatives
09/04/2012US8258096 Therapy procedure for drug delivery for trigeminal pain
09/04/2012US8258095 Method of controlling glycemia by ultrarapid acting insulin without adjusting an insulin dose for meal content
09/04/2012US8258094 Analogs of ghrelin
09/04/2012US8257943 Process for producing dipeptides or dipeptide derivatives
09/04/2012US8257927 Hereditary hemochromatosis gene
09/04/2012US8257758 Process for the extraction, purification and enzymatic modification of soy 7S globulin alpha' subunit for use as hypocholesterolemizing agent
09/04/2012US8257745 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
09/04/2012US8257735 Method of increasing the bioavailability of recombinant human insulin isophane in a patient
09/04/2012US8257728 Metal implant coated under reduced oxygen concentration with osteoinductive protein
09/04/2012US8257714 Compositions and methods for immunotherapy of cancer and infectious diseases
09/04/2012US8257711 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
09/04/2012US8257702 Compositions with hematopoietic and immune activity
09/04/2012US8257700 Proteomic analysis of active multiple sclerosis lesions
09/04/2012US8257699 Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
09/04/2012US8257698 Protein engineering of monoacylglycerol lipase (MGLL)
09/04/2012US8257697 Use of platelet activating factor acetylhydrolase as biomarker for anaphylaxis
09/04/2012US8257691 Composition and dosage form comprising a particle formulation and suspending vehicle
09/04/2012US8257687 Photostabilization of coenzyme Q compounds with alkoxycrylene compounds
09/04/2012US8257686 Compositions and methods relating to prevention of chemotherapy-induced alopecia
09/04/2012CA2615022C Hcv ns3 protease inhibitors
09/04/2012CA2610646C Prevascularized devices and related methods
09/04/2012CA2555339C Pharmaceutical formulations comprising paraoxonase
09/04/2012CA2541834C Modified whole cell, cell extract and omv-based vaccines
09/04/2012CA2520279C Mutant vesicular stomatitis viruses and use thereof
09/04/2012CA2471812C Targeted retrograde gene delivery to motor neurons